keyword
https://read.qxmd.com/read/38656458/correction-gpr18-agonist-resolvin-d2-reduces-early-brain-injury-in-a-rat-model-of-subarachnoid-hemorrhage-by-multiple-protective-mechanisms
#1
Tongyu Zhang, Gang Zuo, Hongqi Zhang
No abstract text is available yet for this article.
April 24, 2024: Cellular and Molecular Neurobiology
https://read.qxmd.com/read/38641607/can-essential-fatty-acids-efas-prevent-and-ameliorate-post-covid-19-long-haul-manifestations
#2
REVIEW
Undurti N Das
It is hypothesized that COVID-19, post-COVID and post-mRNA COVID-19 (and other related) vaccine manifestations including "long haul syndrome" are due to deficiency of essential fatty acids (EFAs) and dysregulation of their metabolism. This proposal is based on the observation that EFAs and their metabolites can modulate the swift immunostimulatory response of SARS-CoV-2 and similar enveloped viruses, suppress inappropriate cytokine release, possess cytoprotective action, modulate serotonin and bradykinin production and other neurotransmitters, inhibit NF-kB activation, regulate cGAS-STING pathway, modulate gut microbiota, inhibit platelet activation, regulate macrophage and leukocyte function, enhance wound healing and facilitate tissue regeneration and restore homeostasis...
April 19, 2024: Lipids in Health and Disease
https://read.qxmd.com/read/38639268/resolvin-d1-level-during-different-trimesters-of-pregnancy-for-predicting-the-risk-of-fetal-growth-retardation-in-elderly-pregnancy
#3
JOURNAL ARTICLE
Ying Han, Dandan Wang, Shufang Cai, Lina Zhang, Jingxian Xue
Resolvin D1 (RvD1) is potentially associated with fetal growth retardation (FGR) through alleviating maternal inflammation and its linkage with several pregnancy complications. Thus, this study detected RvD1 levels at different trimesters of pregnancy, aiming to investigate its role in predicting FGR risk of elderly pregnant women. This prospective, observational cohort study enrolled 165 elderly pregnant women aged ≥35 years. Serum RvD1 was detected at 10-13 weeks (early pregnancy), 20-23 weeks (middle pregnancy), and 30-33 weeks (late pregnancy) of gestational week by enzyme-linked immunosorbent assay...
April 19, 2024: Scandinavian Journal of Clinical and Laboratory Investigation
https://read.qxmd.com/read/38633251/omega-3-and-omega-6-polyunsaturated-fatty-acids-and-their-potential-therapeutic-role-in-protozoan-infections
#4
REVIEW
Sajid Ur Rahman, Tzu-Nin Weng, Abdul Qadeer, Saqib Nawaz, Hanif Ullah, Chien-Chin Chen
Protozoa exert a serious global threat of growing concern to human, and animal, and there is a need for the advancement of novel therapeutic strategies to effectively treat or mitigate the impact of associated diseases. Omega polyunsaturated fatty acids (ω-PUFAs), including Omega-3 (ω-3) and omega-6 (ω-6), are constituents derived from various natural sources, have gained significant attention for their therapeutic role in parasitic infections and a variety of essential structural and regulatory functions in animals and humans...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38627683/the-relationship-between-serum-resolvin-d1-nlrp3-cytokine-levels-and-adolescents-with-first-episode-medication-na%C3%A3-ve-major-depressive-disorder
#5
JOURNAL ARTICLE
Jiamei Guo, Tanwei Zhang, Wanjun Chen, Jianyu Tan, Xiao Li, Anhai Zheng, Yixiao Fu, Tian Qiu
BACKGROUND: Inflammation has become a critical pathological mechanism of Major Depressive Disorder (MDD). NLRP3 is a critical inflammatory pathway to maintain the immune balance. Recently, preclinical evidence showed that Resolvin D1 might potentially offer a new option for antidepressant treatment due to its protective effects through the inhibition of neuroinflammation. However, whether they have clinical value in the diagnosis and treatment evaluation of adolescent depression was unclear...
April 16, 2024: BMC Psychiatry
https://read.qxmd.com/read/38613004/impact-of-1-year-supplementation-with-high-rich-docosahexaenoic-acid-dha-on-clinical-variables-and-inflammatory-biomarkers-in-pediatric-cystic-fibrosis-a-randomized-double-blind-controlled-trial
#6
JOURNAL ARTICLE
Roser Ayats-Vidal, Montserrat Bosque-García, Begoña Cordobilla, Oscar Asensio-De la Cruz, Miguel García-González, Susana Loureda-Pérez, Elena Fernández-López, Eva Robert-Barriocanal, Andrea Valiente-Planas, Joan Carles Domingo
A randomized, double-blind, and placebo-controlled study was conducted to assess the effect of dietary supplementation with high-rich docosahexaenoic acid (DHA) (Tridocosahexanoin-AOX® 70%) at 50 mg/kg/day in pediatric patients with cystic fibrosis (CF) as compared with placebo. The duration of supplementation was 12 months. A total of 22 patients were included, with 11 in the DHA group and 11 in the placebo group. The mean age was 11.7 years. The outcome variables were pulmonary function, exacerbations, sputum cellularity, inflammatory biomarkers in sputum and peripheral blood, and anthropometric variables...
March 27, 2024: Nutrients
https://read.qxmd.com/read/38608525/resolvin-d2-prevents-vascular-remodeling-hypercontractility-and-endothelial-dysfunction-in-obese-hypertensive-mice-through-modulation-of-vascular-and-proinflammatory-factors
#7
JOURNAL ARTICLE
Raquel Rodrigues-Diez, Constanza Ballesteros-Martinez, Rosa María Moreno-Carriles, Francisco Nistal, Lucía S Díaz Del Campo, Victoria Cachofeiro, Jesmond Dalli, Ana B García-Redondo, Juan M Redondo, Mercedes Salaices, Ana M Briones
During resolution of inflammation, specialized proresolving mediators (SPMs), including resolvins, are produced to restore tissue homeostasis. We hypothesized that there might be a dysregulation of SPMs pathways in pathological vascular remodeling and that resolvin D2 (RvD2) might prevent vascular remodeling and contractile and endothelial dysfunction in a model of obesity and hypertension. In aortic samples of patients with or without abdominal aortic aneurysms (AAA), we evaluated gene expression of enzymes involved in SPMs synthesis (ALOXs), SPMs receptors and pro-inflammatory genes...
April 11, 2024: Biomedicine & Pharmacotherapy
https://read.qxmd.com/read/38605741/effect-of-intra-ovarian-injection-of-mesenchymal-stem-cells-or-its-conditioned-media-on-repeated-opu-ivep-outcomes-in-jersey-heifers-and-its-relationship-with-follicular-fluid-inflammatory-markers
#8
JOURNAL ARTICLE
Ali Sarvari, Amir Niasari-Naslaji, Abolfazl Shirazi, Banafsheh Heidari, Sara Borjian Boroujeni, Mohammad Hossein Moradi, Mohammad-Mahdi Naderi, Bahareh Behzadi, Mohammad-Mahdi Mehrazar, Mohammad Mehdi Dehghan
BACKGROUND: Repeated Ovum Pick Up (OPU) could have a detrimental effect on ovarian function, reducing In Vitro Embryo Production (IVEP). The present study examined the therapeutic effect of adipose-derived Mesenchymal Stem Cells (MSCs) or its Conditioned Medium (ConM) on ovarian trauma following repeated OPU. Resolvin E1 (RvE1) and Interleukin-12 (IL-12) were investigated as biomarkers. METHODS: Jersey heifers (n=8) experienced 11 OPU sessions including 5 pre-treatment and 6 treatment sessions...
2024: Avicenna Journal of Medical Biotechnology
https://read.qxmd.com/read/38561794/resolvin-d1-alleviates-apoptosis-triggered-by-endoplasmic-reticulum-stress-in-ipec-j2-cells
#9
JOURNAL ARTICLE
Siyuan Zhu, Jingbo Liu, Qi Wang, Yong Yang, Lei Du, Xiaoyu Qiu, Renli Qi, Jing Wang
BACKGROUND: Resolvin D1 (RvD1), a specialized pro-resolving lipid mediator (SPM), is derived from docosahexaenoic acid (DHA). It plays a key role in actively resolving inflammatory responses, which further reduces small intestinal damage. However, its regulation of the apoptosis triggered by endoplasmic reticulum (ER) stress in intestinal epithelial cells is still poorly understood. The intestinal porcine epithelial cells (IPEC-J2) were stimulated with tunicamycin to screen an optimal stimulation time and concentration to establish an ER stress model...
April 1, 2024: BMC Veterinary Research
https://read.qxmd.com/read/38551610/resolvin-d2-attenuates-lps-induced-macrophage-exhaustion
#10
JOURNAL ARTICLE
Cristina M Padovani, Rachael M Wilson, Ana Rodriguez, Bernd W Spur, Kingsley Yin
Early in sepsis, a hyperinflammatory response is dominant, but later, an immunosuppressive phase dominates, and the host is susceptible to opportunistic infections. Anti-inflammatory agents may accelerate the host into immunosuppression, and few agents can reverse immunosuppression without causing inflammation. Specialized pro-resolving mediators (SPMs) such as resolvin D2 (RvD2) have been reported to resolve inflammation without being immunosuppressive, but little work has been conducted to examine their effects on immunosuppression...
April 15, 2024: FASEB Journal: Official Publication of the Federation of American Societies for Experimental Biology
https://read.qxmd.com/read/38542895/uncovering-the-power-of-gpr18-signalling-how-rvd2-and-other-ligands-could-have-the-potential-to-modulate-and-resolve-inflammation-in-various-health-disorders
#11
REVIEW
Ewelina Honkisz-Orzechowska, Dorota Łażewska, Grzegorz Baran, Katarzyna Kieć-Kononowicz
The resolution of inflammation is the primary domain of specialised pro-resolving mediators (SPMs), which include resolvins, protectins, and their forms synthesised under the influence of aspirin and the maresins. The role of these SPMs has been discussed by many authors in the literature, with particular reference to neuroinflammation and significant neurological disorders. This review discusses the role of G protein-coupled receptor 18 (GPR18), resolvin D2 (RvD2) activity, and the GPR18-RvD2 signalling axis, as well as the role of small molecule ligands of GPR18 in inflammation in various health disorders (brain injuries, neuropathic pain, neurodegenerative/cardiometabolic/cardiovascular/gastrointestinal diseases, peritonitis, periodontitis, asthma and lung inflammation, Duchenne muscular dystrophy, SARS-CoV-2-induced inflammation, and placenta disorders...
March 12, 2024: Molecules: a Journal of Synthetic Chemistry and Natural Product Chemistry
https://read.qxmd.com/read/38518540/joint-effects-of-one-year-of-marine-omega-3-fatty-acid-supplementation-and-participant-dietary-fish-intake-upon-circulating-lipid-mediators-of-inflammation-resolution-in-a-randomized-controlled-trial
#12
JOURNAL ARTICLE
Emily G Oakes, Iliyan Vlasakov, Gregory Kotler, Vadim Bubes, Samia Mora, Raju Tatituri, Nancy R Cook, JoAnn E Manson, Karen H Costenbader
OBJECTIVES: We assessed the joint effects of omega (n)-3 fatty acid supplementation and dietary fish intake on systemic lipid mediators of inflammation among adults. METHODS: Within VITAL, a double-blind randomized controlled trial, adults were randomized to ω-3 fatty acids (460 mg EPA + 380 mg DHA/d) or placebo. We selected participants who reported low (<1 serving/mo) baseline dietary fish intake and matched them by age, sex, race, and trial arm to participants with self-reported highest fish intake (≥3...
February 28, 2024: Nutrition
https://read.qxmd.com/read/38499284/enhanced-baculoviral-virulence-by-suppressing-the-degradation-of-an-insect-immune-resolvin-epoxyoctadecamonoenoic-acid-in-three-lepidopteran-insects
#13
JOURNAL ARTICLE
Niayesh Shahmohammadi, Mojtaba Esmaeily, Eticha Abdisa, Eeshita Mandal, Yonggyun Kim
Epoxyoctadecamonoenoic acids (EpOMEs) are produced from linoleic acid by a cytochrome P450 monooxygenase (CYP) and play a crucial role in terminating excessive and unnecessary immune responses during the late infection stage in insects. This suggests that an increase in the EpOME level may enhance the virulence of insect pathogens against pests. This study tested this hypothesis using a specific inhibitor against soluble epoxide hydrolase (sEH) to degrade EpOMEs, which leads to elevated endogenous EpOME levels...
March 16, 2024: Journal of Invertebrate Pathology
https://read.qxmd.com/read/38498346/resolvin-d2-limits-atherosclerosis-progression-via-myeloid-cell-gpr18
#14
JOURNAL ARTICLE
Masharh Lipscomb, Sean Walis, Michael Marinello, Hebe Agustina Mena, Katherine C MacNamara, Matthew Spite, Gabrielle Fredman
Dysregulated inflammation-resolution programs are associated with atherosclerosis progression. Resolvins, in part, mediate inflammation-resolution programs. Indeed, Resolvin D2 (RvD2) activates GPR18, a G-protein-coupled receptor, and limits plaque progression, though the cellular targets of RvD2 remain unknown. Here, we developed a humanized GPR18 floxed ("fl/fl") and a myeloid (Lysozyme M Cre) GPR18 knockout (mKO) mouse. We functionally validated this model by assessing efferocytosis in bone marrow-derived macrophages (BMDMs) and found that RvD2 enhanced efferocytosis in the fl/fl, but not in the mKO BMDMs...
March 31, 2024: FASEB Journal: Official Publication of the Federation of American Societies for Experimental Biology
https://read.qxmd.com/read/38485346/chronic-stress-alters-lipid-mediator-profiles-associated-with-immune-related-gene-expressions-and-cell-compositions-in-mouse-bone-marrow-and-spleen
#15
JOURNAL ARTICLE
Io Horikawa, Hirotaka Nagai, Masayuki Taniguchi, Guowei Chen, Masakazu Shinohara, Tomohide Suzuki, Shinichi Ishii, Yoshio Katayama, Shiho Kitaoka, Tomoyuki Furuyashiki
Despite the importance of lipid mediators in stress and depression and their link to inflammation, the influence of stress on these mediators and their role in inflammation is not fully understood. This study used RNA-seq, LC-MS/MS, and flow cytometry analyses in a mouse model subjected to chronic social defeat stress to explore the effects of acute and chronic stress on lipid mediators, gene expression, and cell population in the bone marrow and spleen. In the bone marrow, chronic stress induced a sustained transition from lymphoid to myeloid cells, accompanied by corresponding changes in gene expression...
April 2024: Journal of Pharmacological Sciences
https://read.qxmd.com/read/38485285/resolvins-protect-against-diabetes-induced-colonic-oxidative-stress-barrier-dysfunction-and-associated-diarrhea-via-the-ho-1-pathway
#16
JOURNAL ARTICLE
Ting Yu, Die Chen, Hongyan Qi, Lin Lin, Yurong Tang
Diabetes is associated with increased oxidative stress, leading to altered tight junction formation and increased apoptosis in colonic epithelial cells. These changes may lead to intestinal barrier dysfunction and corresponding gastrointestinal symptoms in patients with diabetes, including diarrhea. The aim of this study was to characterize the effect and mechanism of Resolvin D1 (RvD1) on diabetes-induced oxidative stress and barrier disruption in the colon. Mice with streptozotocin-induced diabetes were treated with RvD1 for 2 weeks, then evaluated for stool frequency, stool water content, gut permeability, and colonic transepithelial electrical resistance as well as production of reactive oxygen species (ROS), apoptosis, and expression of tight junction proteins Zonula Occludens 1 (ZO-1) and occludin...
March 14, 2024: BioFactors
https://read.qxmd.com/read/38464077/resolvin-d2-gpr18-signaling-enhances-monocytic-myeloid-derived-suppressor-cell-function-to-mitigate-abdominal-aortic-aneurysm-formation
#17
Paolo Bellotti, Zachary Ladd, Victoria Leroy, Gang Su, Shiven Sharma, Joseph B Hartman, Jonathan Krebs, Chelsea Viscardi, Robert Maile, Lyle L Moldawer, Phillip Efron, Ashish K Sharma, Gilbert R Upchurch
Abdominal aortic aneurysm (AAA) formation is a chronic vascular pathology characterized by inflammation, leukocyte infiltration and vascular remodeling. The aim of this study was to delineate the protective role of Resolvin D2 (RvD2), a bioactive isoform of specialized proresolving lipid mediators, via G-protein coupled receptor 18 (GPR18) receptor signaling in attenuating AAAs. Importantly, RvD2 and GPR18 levels were significantly decreased in aortic tissue of AAA patients compared with controls. Furthermore, using an established murine model of AAA in C57BL/6 (WT) mice, we observed that treatment with RvD2 significantly attenuated aortic diameter, pro-inflammatory cytokine production, immune cell infiltration (neutrophils and macrophages), elastic fiber disruption and increased smooth muscle cell α-actin expression as well as increased TGF-β2 and IL-10 expressions compared to untreated mice...
February 26, 2024: bioRxiv
https://read.qxmd.com/read/38460760/anti-inflammatory-actions-of-aspirin-triggered-resolvin-d1-at-rvd1-in-bronchial-epithelial-cells-stimulated-by-cigarette-smoke-extract
#18
JOURNAL ARTICLE
Jhony Robson de Oliveira, Aline Beatriz Mahler Pereira, Henrique Ismarsi de Souza, Wanessa Maria Dos Santos, Thaís Sorares Farnesi de Assunção, Fernanda Bernadelli de Vito, Helio Moraes de Souza, Paulo Roberto da Silva, Marcos Vinicius da Silva, Virmondes Rodrigues Junior, Alexandre de Paula Rogerio
Smoking causes several diseases such as chronic obstructive pulmonary disease (COPD). Aspirin-triggered-resolvin D1 (AT-RvD1) is a lipid mediator produced during the resolution of inflammation and demonstrates anti-inflammatory and pro-resolution effects in several inflammatory experimental models including in the airways. Here we evaluated the role of AT-RvD1 (100nM) in bronchial epithelial cells (BEAS-2B) stimulated by cigarette smoke extract (CSE; 1%; 1 cigarette) for 24h. CSE induced the productions of IL-1β, TNF-α, IL-10, IL-4 and IFN-γ as well as the activations of NF-κB and STAT3 and the expression of ALX/FPR2 receptor...
March 7, 2024: Prostaglandins & Other Lipid Mediators
https://read.qxmd.com/read/38450161/oral-clostridium-butyricum-on-mice-endometritis-through-uterine-microbiome-and-metabolic-alternations
#19
JOURNAL ARTICLE
Mao Hagihara, Tadashi Ariyoshi, Shuhei Eguchi, Kentaro Oka, Motomichi Takahashi, Hideo Kato, Yuichi Shibata, Takumi Umemura, Takeshi Mori, Narimi Miyazaki, Jun Hirai, Nobuhiro Asai, Nobuaki Mori, Hiroshige Mikamo
Endometritis occurs frequently in humans and animals, which can negatively affect fertility and cause preterm parturition syndrome. Orally administered Clostridium butyricum , a butyrate-producing gram-positive anaerobe, exhibits anti-inflammatory effects. However, the precise mechanism by which Clostridium butyricum attenuates endometritis remains unclear. This in vivo study evaluated the anti-inflammatory effects of orally administered Clostridium butyricum on uterine tissues. In addition, we conducted uterine microbiome and lipid metabolome analyses to determine the underlying mechanisms...
2024: Frontiers in Microbiology
https://read.qxmd.com/read/38439570/profiling-of-oxylipins-as-markers-of-oxidative-stress-in-biological-samples
#20
JOURNAL ARTICLE
Liping Yang, Jaewoo Choi, Claudia S Maier, Jan F Stevens
Oxylipins are oxidized metabolites of polyunsaturated fatty acids (PUFAs). They represent a class of risk markers and/or therapeutic targets for diseases associated with inflammation, including cardiovascular disease and brain disorders. Because the biological activities of free PUFAs and oxylipins depend on their chemical structures and concentrations, monitoring PUFAs and oxylipin levels in biological systems is critical for understanding their roles in health and disease. Traditionally, accurate quantification of free PUFAs and oxylipins in biological samples was performed separately, as PUFAs are often 1000-fold more abundant than the derived oxidized fatty acids (oxylipins)...
March 2024: Current protocols
keyword
keyword
31238
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.